FDA clears Covidien's endotracheal tube

09/30/2009 | Forbes

The FDA has cleared Covidien's Mallinckrodt TaperGuard Evac endotracheal tube, a breathing-assistance device designed for use in intensive care units and emergency rooms. The company said the new version of the device potentially could lower the risk of post-surgical complications.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care